HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis.

AbstractOBJECTIVE:
We have shown that connective tissue growth factor (CTGF) plays an important role in the pathogenesis of rheumatoid arthritis (RA). This study was undertaken to evaluate the effects of blockade of the CTGF pathway on the development of collagen-induced arthritis (CIA) in mice.
METHODS:
Arthritis was induced in DBA/1J mice by immunization with a combination of type II collagen (CII) and Freund's complete adjuvant. We evaluated the development of arthritis in mice with CIA left untreated versus treated with neutralizing anti-CTGF monoclonal antibody (mAb).
RESULTS:
Inhibition of CTGF in mice treated with neutralizing anti-CTGF mAb significantly ameliorated arthritis compared to the untreated mice with CIA. Serum levels of matrix metalloproteinase 3 were reduced by anti-CTGF mAb treatment. Moreover, blockade of CTGF decreased interleukin-17 expression on purified CD4+ T lymphocytes. Although the expression of the retinoic acid receptor-related orphan receptor γt gene was not suppressed by anti-CTGF mAb treatment, that of interferon regulatory factor 4 (IRF-4) and IκBζ (Nfkbiz), which are other important molecules for the differentiation of Th17 cells, was suppressed. In addition, blockade of CTGF inhibited pathologic proliferation of T lymphocytes in response to CII restimulation in vitro. Moreover, aberrant osteoclastogenesis in mice with CIA was restored by anti-CTGF mAb treatment.
CONCLUSION:
Our findings indicate that blockade of CTGF prevents the progression of arthritis in mice with CIA. Anti-CTGF mAb treatment suppresses pathologic T cell function and restores aberrant osteoclastogenesis in mice with CIA. CTGF may become a new target for the treatment of RA.
AuthorsKazuhisa Nozawa, Maki Fujishiro, Mikiko Kawasaki, Ayako Yamaguchi, Keigo Ikeda, Shinji Morimoto, Kazuhisa Iwabuchi, Mitsuaki Yanagida, Shouzo Ichinose, Megumi Morioka, Hideoki Ogawa, Kenji Takamori, Yoshinari Takasaki, Iwao Sekigawa
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 65 Issue 6 Pg. 1477-86 (Jun 2013) ISSN: 1529-0131 [Electronic] United States
PMID23436223 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 by the American College of Rheumatology.
Chemical References
  • Antibodies, Monoclonal
  • Connective Tissue Growth Factor
Topics
  • Animals
  • Antibodies, Monoclonal (immunology, pharmacology)
  • Arthritis, Experimental (drug therapy, immunology)
  • Arthritis, Rheumatoid (drug therapy, immunology)
  • Connective Tissue Growth Factor (antagonists & inhibitors)
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Immunoblotting
  • Immunohistochemistry
  • Lymphocyte Activation (drug effects, immunology)
  • Mice
  • Mice, Inbred DBA
  • Microarray Analysis
  • Real-Time Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: